Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Messenger, Mike
31  Ergebnisse:
Personensuche X
?
1

Development and validation of multivariable machine learnin..:

Savage, Richard ; Messenger, Mike ; Neal, Richard D...
BMJ Open.  12 (2022)  4 - p. e053590 , 2022
Link: https://doi.org/10.1136/..
 
?
2

Identifying Novel Biomarkers Ready for Evaluation in Low-Pr..:

Druce, Paige ; Calanzani, Natalia ; Snudden, Claudia...
Advances in Therapy.  38 (2021)  6 - p. 3032-3065 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Identifying Novel Biomarkers Ready for Evaluation in Low-Pr..:

Calanzani, Natalia ; Druce, Paige E. ; Snudden, Claudia...
Advances in Therapy.  38 (2020)  2 - p. 793-834 , 2020
Link: https://doi.org/10.1007/..
 
?
4

Unmet clinical needs for COVID-19 tests in UK health and so..:

Graziadio, Sara ; Urwin, Samuel G. ; Cocco, Paola...
PLOS ONE.  15 (2020)  11 - p. e0242125 , 2020
Link: https://doi.org/10.1371/..
 
?
5

Yorkshire Lung Screening Trial (YLST): protocol for a rando..:

Crosbie, Philip AJ ; Gabe, Rhian ; Simmonds, Irene...
BMJ Open.  10 (2020)  9 - p. e037075 , 2020
Link: https://doi.org/10.1136/..
 
?
6

The Role of Measurement Uncertainty in Health Technology As..:

Smith, Alison F. ; Messenger, Mike ; Hall, Peter.
PharmacoEconomics.  36 (2018)  7 - p. 823-835 , 2018
Link: https://doi.org/10.1007/..
 
?
7

Toward a Framework for Outcome-Based Analytical Performance..:

Smith, Alison F ; Shinkins, Bethany ; Hall, Peter S..
Clinical Chemistry.  65 (2019)  11 - p. 1363-1374 , 2019
Link: https://doi.org/10.1373/..
 
?
8

Development and validation of multivariable machine learnin..:

Savage, Richard ; Messenger, Mike ; Neal, Richard D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977764/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Identifying Novel Biomarkers Ready for Evaluation in Low-Pr..:

Calanzani, Natalia ; Druce, Paige E ; Snudden, Claudia...
Advances in Therapy.  , 2021
Link: https://hdl.handle.net/2..
 
?
10

Identifying Novel Biomarkers Ready for Evaluation in Low-Pr..:

Druce, Paige ; Calanzani, Natalia ; Snudden, Claudia...
Advances in Therapy.  , 2021
Link: https://hdl.handle.net/2..
 
?
11

Identifying Novel Biomarkers Ready for Evaluation in Low-Pr..:

Druce, Paige ; Calanzani, Natalia ; Snudden, Claudia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078393/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
12

Identifying Novel Biomarkers Ready for Evaluation in Low-Pr..:

Calanzani, Natalia ; Druce, Paige E ; Snudden, Claudia...
doi:10.17863/CAM.64956.  , 2021
Link: https://doi.org/10.17863..
 
?
13

Yorkshire Lung Screening Trial (YLST): protocol for a rando..:

Crosbie, Philip Aj ; Gabe, Rhian ; Simmonds, Irene...
https://hull-repository.worktribe.com/output/3618042.  , 2020
Link: https://hull-repository...
 
?
14

Yorkshire Lung Screening Trial (YLST):protocol for a random..:

Crosbie, Philip A.J ; Gabe, Rhian ; Simmonds, Irene...
Crosbie , P A J , Gabe , R , Simmonds , I , Kennedy , M , Rogerson , S , Ahmed , N , Baldwin , D R , Booton , R , Cochrane , A , Darby , M , Franks , K , Hinde , S , Janes , S M , MacLeod , U , Messenger , M , Moller , H , Murray , R L , Neal , R D , Quaife , S L , Sculpher , M , Tharmanathan , P , Torgerson , D & Callister , M E J 2020 , ' Yorkshire Lung Screening Trial (YLST) : protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk ' , BMJ Open , vol. 10 , no. 9 , e037075 , pp. 1-10 . https://doi.org/10.1136/bmjopen-2020-037075.  , 2020
Link: https://research.manches..
 
?
15

Identifying Novel Biomarkers Ready for Evaluation in Low-Pr..:

Calanzani, Natalia ; Druce, Paige E ; Snudden, Claudia...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889689/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
1-15